Cost effectiveness: summary.
Ringel
Steven P
SP
University of Colorado Health Science Center, Denver, CO, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000191:economics*; D001291:Attitude of Health Personnel; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005102:Health Expenditures; D006801:Humans; D018696:Neuroprotective Agents / Q000191:economics / Q000627:therapeutic use; D040841:Resource Allocation; D019782:Riluzole / Q000191:economics / Q000627:therapeutic use
D018696:Neuroprotective Agents; D019782:Riluzole